STAIDSON Trademark

Trademark Overview


On Tuesday, April 1, 2014, a trademark application was filed for STAIDSON with the United States Patent and Trademark Office. The USPTO has given the STAIDSON trademark a serial number of 86238081. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 24, 2021. This trademark is owned by Staidson(Beijing) Biopharmaceuticals Co., Ltd.. The STAIDSON trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes, for the treatment of injury of optic nerve; Medicines for human purposes, for the treatment of functional constipation and for treatment of intestinal conditions; Medicines for human purposes, for the treatment of diabetes; Medicines for human purposes, for the treatment of acute and chronic inflammatory arthritis, soft tissue rheumatism, soft tissue injury and injury pain; Medicines, namely, acetylsalicylic acid tablets for treatment of antithrombosis and for the treatment of unstable angina; Medicines for human purposes, for the treatment of pruritus and alopecia; Medicines for human purposes, for weight loss; Medicines for human purposes, for treatment of hemostasis; Medicines for human purposes, for the treatment of hepatitis B, Aids, retinal pigment degeneration and glioma; Medicines for human purposes, for the treatment of frequent micturition, urgency of urination and urge urinary incontinence; Supplementary medicines for human purposes, for the tre...
staidson

General Information


Serial Number86238081
Word MarkSTAIDSON
Filing DateTuesday, April 1, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 24, 2021
Registration Number4689978
Registration DateTuesday, February 17, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 19, 2014

Trademark Statements


Goods and ServicesMedicines for human purposes, for the treatment of injury of optic nerve; Medicines for human purposes, for the treatment of functional constipation and for treatment of intestinal conditions; Medicines for human purposes, for the treatment of diabetes; Medicines for human purposes, for the treatment of acute and chronic inflammatory arthritis, soft tissue rheumatism, soft tissue injury and injury pain; Medicines, namely, acetylsalicylic acid tablets for treatment of antithrombosis and for the treatment of unstable angina; Medicines for human purposes, for the treatment of pruritus and alopecia; Medicines for human purposes, for weight loss; Medicines for human purposes, for treatment of hemostasis; Medicines for human purposes, for the treatment of hepatitis B, Aids, retinal pigment degeneration and glioma; Medicines for human purposes, for the treatment of frequent micturition, urgency of urination and urge urinary incontinence; Supplementary medicines for human purposes, for the treatment of pain of muscle cramp caused by inflammation and injury; Medicines for human purposes, for the treatment of gastric ulcer, duodenal ulcer and chronic gastritis; Medicines for human purposes, for the treatment of infectious disease; Pharmaceutical preparations for the treatment of autoimmune disorders; Medicines for treating constipation

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 24, 2021
Primary Code005
First Use Anywhere DateFriday, September 19, 2014
First Use In Commerce DateFriday, September 19, 2014

Trademark Owner History


Party NameStaidson(Beijing) Biopharmaceuticals Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBeijing
CN

Party NameStaidson(Beijing) Biopharmaceuticals Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBeijing
CN

Party NameStaidson(Beijing) Biopharmaceuticals Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBeijing
CN

Trademark Events


Event DateEvent Description
Friday, September 24, 2021CANCELLED SEC. 8 (6-YR)
Monday, February 17, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 17, 2015REGISTERED-PRINCIPAL REGISTER
Friday, January 16, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, January 15, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 7, 2015STATEMENT OF USE PROCESSING COMPLETE
Friday, November 21, 2014USE AMENDMENT FILED
Tuesday, January 6, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 21, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, October 14, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 19, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 19, 2014PUBLISHED FOR OPPOSITION
Wednesday, July 30, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 14, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 14, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 14, 2014EXAMINER'S AMENDMENT ENTERED
Friday, July 11, 2014ASSIGNED TO LIE
Friday, July 11, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 11, 2014EXAMINERS AMENDMENT E-MAILED
Friday, July 11, 2014EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 8, 2014ASSIGNED TO EXAMINER
Monday, April 14, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 4, 2014NEW APPLICATION ENTERED IN TRAM